Indications for other tests
- 11 Dec 2023
- 1 Minute to read
- Print
- PDF
Indications for other tests
- Updated on 11 Dec 2023
- 1 Minute to read
- Print
- PDF
Article summary
Did you find this summary helpful?
Thank you for your feedback
The diagnosis of the perimenopause or menopause should be based on symptoms alone without additional tests.
Other investigations are not usually required UNLESS:
- There is any uncertainty about the diagnosis or red flags are present.
- The provisional diagnosis is premature ovarian insufficiency meaning additional work up investigations are recommended.
- The provisional diagnosis is early menopause (age 40–44 years) meaning FSH levels may be considered.
- Testosterone is being considered, meaning a total testosterone level should be undertaken.
NOTE:
- FSH levels should not be performed in women >45 years to assess menopausal status.
- Symptoms of hypothyroidism can be similar to menopause symptoms.
References and Further Information:
- Hamoda H, Panay N, Pedder H et al. The British Menopause Society & Women's Health Concern 2020 recommendations on hormone replacement therapy in menopausal women. Post Reproductive Health 2020. Found on page 193.
- Menopause Practice Standards produced by the British Menopause Society (BMS), Royal College of Obstetricians and Gynaecologists (RCOG), Society for Endocrinology (SfE), Faculty of Sexual and Reproductive Health (FSRH), Faculty of Pharmaceutical Medicine (FPM) and Royal Pharmaceutical Society (RPS). 2022. Standard 7.
- NICE CKS Guidance. Menopause. Diagnosis. Last updated Sept 2022.
- ESHRE Guideline on the management of premature ovarian insufficiency. Guideline of the European Society of Human Reproduction and Embryology. POI Guideline Development Group. Dec 2015.
- BMS Statement. HRT Prescribing. British Menopause Society. 2022.
Was this article helpful?